5α-Reductases in Human Physiology: An Unfolding Story

    November 2012 in “ Endocrine Practice
    Abdulmaged M. Traish
    Image of study
    TLDR Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.
    The 2012 study "5α-Reductases in Human Physiology: An Unfolding Story" explored the function of 5α-reductases, enzymes that convert hormones into a subclass of neuroactive steroid hormones. These hormones have various physiological roles, including sexual differentiation, neuroprotection, memory enhancement, anxiety regulation, sleep, and stress. The study also discussed the use of 5α-reductase inhibitors in treating conditions like benign prostatic hyperplasia and androgenetic alopecia. However, it stressed the need for a deeper understanding of 5α-reductases and neuroactive steroids to reduce potential side effects of these inhibitors, particularly on the central nervous system. The study was based on a literature review from 1970 to 2011.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 95 results

      community Proof that finasteride messes with neurosteroids

      in Research/Science  230 upvotes 6 months ago
      Finasteride can impact neurosteroids, potentially causing depression and other side effects in some users. Despite these concerns, many continue using it for hair loss, with some switching to topical applications to mitigate side effects.
      [object Object]

      community A hill on which I will die: The DHT itch absolutely exists

      in Research/Science  209 upvotes 8 months ago
      The DHT itch is linked to hair loss and persists despite finasteride use; switching to dutasteride helped alleviate the itch and promoted regrowth. Some users suggest seborrheic dermatitis as a cause and recommend treatments like medicated shampoos, vitamin D, and minoxidil.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 4 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

    Similar Research

    5 / 1000+ results